CLINICAL_TRIALS
trial_result
· 2015-06-29
Clinical Trial Update: A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib [Phase 1]
Summary
A completed Phase 1 safety study evaluating LY2127399 in combination with bortezomib for multiple myeloma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Applied Molecular Evolution | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED